Evaluation of OATP1B inhibitory potential using an endogenous biomarker coproporphyrin-I in new drug applications: Case reports submitted by 2024.

Saved in:
Bibliographic Details
Title: Evaluation of OATP1B inhibitory potential using an endogenous biomarker coproporphyrin-I in new drug applications: Case reports submitted by 2024.
Authors: Watari R; Laboratory for Drug Discovery and Development, Shionogi & Co., Ltd, Japan. Electronic address: ryosuke.watari@shionogi.co.jp.
Source: Drug metabolism and pharmacokinetics [Drug Metab Pharmacokinet] 2026 Feb; Vol. 66, pp. 101513. Date of Electronic Publication: 2025 Dec 17.
Publication Type: Journal Article; Review
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 101164773 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1880-0920 (Electronic) Linking ISSN: 13474367 NLM ISO Abbreviation: Drug Metab Pharmacokinet Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1880-0920
DOI:10.1016/j.dmpk.2025.101513